Clinical Study

A Trial Of Fixed-Dose Brexpiprazole With Sertraline In The Treatment Of Post-Traumatic Stress Disorder

Posted Date: Oct 30, 2019

  • Investigator: Susan Lynn Mcelroy
  • Specialties:
  • Type of Study: Drug

This will be a 12-week, multi-center, randomized, double-blind trial evaluating the efficacy, safety, and tolerability of fixed-dose brexpiprazole + sertraline combination treatment in adult subjects with PTSD. The trial will consist of a screening period (up to 14 days), a 12-week, double-blind treatment period, and follow-up.


Male And Female Outpatients 18 To 65 Years Of Age, Inclusive, At The Time Of Informed Consent.


Ptsd, Post-Traumatic Stress Disorder, Brexpiprazole

For More Information:

Brian Martens

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.